9 Meters Biopharma Income Tax

The latest income tax for NMTR is $3.5M as of March 2023. That compares with $5.7K in the prior-year period — up 61801.0% year over year. Investors often review this figure alongside 9 Meters Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMTR's income tax moved from $5.7K to $3.5M — a 61801.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 9 Meters Biopharma's operating scale or balance-sheet position.

A income tax figure of $3.5M for NMTR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NMTR's income tax ($3.5M), review year-over-year change from $5.7K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 9 Meters Biopharma's income tax against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.